La cadena de opciones muestra datos clave de las opciones de acciones de FibroGen a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para FibroGen..

FibroGen (NASDAQ:FGEN) Bolsa, Cadena de Opciones

FIBROGEN INC

FibroGen

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Konskie,,Poland,-,March,08,,2025:,Restoration,Hardware,Company,Logo

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADBE

BIAF

CGBS

EONR

FGEN

GNLN

HCTI

HUSA

INDO

NINE

PRZO

RNTX

RSLS

SBET

TPET

TRAW

USEG

VEON

RH sorprende con ganancias positivas en el primer trimestre y mantiene su guía para 2025, mientras sus acciones suben un 18,2 %.

Las acciones de RH se disparan un 18%; Aquí están 20 acciones que se mueven antes de la apertura del mercado

AdobeStockholm,,Sweden,-,July,26,,2021:,A,Wall,Sign,For

ZDGE

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este viernes: ADBE, MNY, RH, FGEN y ZDGE.

5 acciones en el foco este viernes: ADBE, MNY, RH, FGEN y ZDGE

FibroGen Inc

Press Releases

FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

FibroGen to Report First Quarter 2025 Financial Results

Earnings

FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update

Management

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors

FibroGen Announces 1-for-25 Reverse Stock Split

FibroGen to Report Second Quarter 2025 Financial Results

FibroGen Announces Positive Type C Meeting with the FDA for Roxadustat in Patients with Anemia Associated with Lower-Risk Myelodysplastic Syndromes

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

Contracts

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Annovis Bio

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

Generation Bio

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Lantern Pharma

LAVA Therapeutics

MAIA Biotechnology

Medicus Pharma

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

PepGen

Propanc Biopharma

Plus Therapeutics

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Renovaro

Senti Biosciences

Shattuck Labs

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

Comments

FibroGen

FibroGen (FGEN) Opciones

FibroGen (NASDAQ:FGEN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL